BioCentury
ARTICLE | Financial News

Apricus Biosciences completes direct public offering

January 18, 2016 8:00 AM UTC

Apricus Biosciences Inc. (NASDAQ:APRI), San Diego, Calif. Business: Drug delivery, Genitourinary, Cancer Date completed: 2016-01-13 Type: Direct public offering Raised: $2.2 million Shares: 2.5 millio...